4
Changes in Ownership
REGENXBIO Inc. Filed Acc 0001562180-24-003452
President and CEO sold 15,000 shares at $18.19 ($272,871)
- President and CEO acquired 15,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Mills Kenneth T. · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-04-15 | Exercise or conversion : show line 1 in the form 10b5-1 | +15,000 | $3.76 | $56,400 | 423,035 | D |
| 2024-04-15 | Sale : show line 2 in the form 10b5-1 | −15,000 | $18.19 | $272,871 | 408,035 | D |
| Open-market sales · 15,000 sh · avg $18.19 · $272,871 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-04-15 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Options (Right to Buy) | −15,000 | 96,354 | D |
Loading xslF345X05/primarydocument.xml…